Cargando…

Rifampicin resistance in new bacteriologically confirmed pulmonary tuberculosis patients in Cameroon: a cross-sectional survey

OBJECTIVE: In Cameroon, tuberculosis (TB) cases are diagnosed and treated within a nationwide network of 248 diagnostic and treatment centres. In 2016, the centers notified a total of 175 multidrug-resistant (MDR-)TB cases, most of them retreatment cases. According to the WHO, the expected number of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noeske, J., Yakam, A. Nana, Foe, J. L. Abena, Nguafack, D., Kuaban, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090829/ https://www.ncbi.nlm.nih.gov/pubmed/30103831 http://dx.doi.org/10.1186/s13104-018-3675-0

Ejemplares similares

Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon
por: Noeske, Jürgen, et al.
Publicado: (2012)

Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study
por: Merker, Matthias, et al.
Publicado: (2021)

Incidence and factors associated with unfavourable treatment outcome among patients with rifampicin-resistant pulmonary tuberculosis in Yaoundé, Cameroon
por: Kuaban, Alain, et al.
Publicado: (2021)

Prediction of pulmonary tuberculosis treatment outcome in a sub-Saharan African context
por: MOUAFO, JOSEPH MAGLOIRE FOSSOKENG, et al.
Publicado: (2023)

Genetic Structure and Drug Susceptibility Patterns of Mycobacterium tuberculosis Complex Strains Responsible of Human Pulmonary Tuberculosis in the Major Rearing Region in Cameroon
por: Koro Koro, Francioli, et al.
Publicado: (2016)

Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon
por: Mbuh, Teyim Pride, et al.
Publicado: (2019)

Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes
por: Mbu, Eyongetah Tabenyang, et al.
Publicado: (2018)

Prison health services across ten central prisons in Cameroon
por: NOESKE, JÜRGEN, et al.
Publicado: (2023)

Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey
por: Moyo, Sizulu, et al.
Publicado: (2022)

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India
por: Dolla, Chandra Kumar, et al.
Publicado: (2021)

Patient-Pathway Analysis of Tuberculosis Services in Cameroon
por: Titahong, Collins N., et al.
Publicado: (2021)

757. Community Prevalence of Bacteriologically Confirmed Pulmonary Tuberculosis: A 7-Year Retrospective Study
por: Sethuraman, Nandini, et al.
Publicado: (2018)

A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda
por: Kirirabwa, Nicholas Sebuliba, et al.
Publicado: (2019)

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners
por: Tsegaye Sahle, Eliyas, et al.
Publicado: (2019)

Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study
por: Pefura-Yone, Eric Walter, et al.
Publicado: (2014)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Prevalence of bacteriologically-confirmed pulmonary tuberculosis in urban Blantyre, Malawi 2019–20: Substantial decline compared to 2013–14 national survey
por: Feasey, Helena R. A., et al.
Publicado: (2023)

A survey for potentially zoonotic gastrointestinal parasites in domestic cavies in Cameroon (Central Africa)
por: Meutchieye, Felix, et al.
Publicado: (2017)

Sputum smear non-conversion among adult persons with bacteriologically confirmed pulmonary tuberculosis in rural eastern Uganda
por: Izudi, Jonathan, et al.
Publicado: (2020)

The role of chest radiography in the diagnosis of bacteriologically confirmed pulmonary tuberculosis in hospitalised Xpert MTB/RIF-negative patients
por: Kebede, Wakjira, et al.
Publicado: (2021)

Sputum smear grading and associated factors among bacteriologically confirmed pulmonary drug-resistant tuberculosis patients in Ethiopia
por: Kassa, Getahun Molla, et al.
Publicado: (2021)

The Bacteriology of Tuberculosis
por: Henderson, J. R.
Publicado: (1958)

The Bacteriological World
Publicado: (1891)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Tuberculosis yield among contacts of non-pulmonary bacteriologically confirmed index TB patients in the urban setting of central Uganda
por: Kisamba, Herbert, et al.
Publicado: (2022)

Distribution of bacteriologically positive and bacteriologically negative pulmonary tuberculosis in Northwest China: spatiotemporal analysis
por: Jiang, Hualin, et al.
Publicado: (2022)

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries
por: Schwœbel, Valérie, et al.
Publicado: (2020)

Machine learning to predict bacteriologic confirmation of Mycobacterium tuberculosis in infants and very young children
por: Smith, Jonathan P., et al.
Publicado: (2023)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial
por: Bediang, Georges, et al.
Publicado: (2018)

Parasitic fauna of domestic cavies in the western highlands of Cameroon (Central Africa)
por: Kouam, Marc K., et al.
Publicado: (2015)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study
por: Pefura Yone, Eric Walter, et al.
Publicado: (2011)

Sensitisation to mites in a group of patients with asthma in Yaounde, Cameroon: a cross-sectional study
por: Pefura-Yone, Eric Walter, et al.
Publicado: (2014)

Treatment outcomes and factors associated with unfavourable outcome among previously treated tuberculosis patients with isoniazid resistance in four regions of Cameroon
por: Kuaban, Christopher, et al.
Publicado: (2020)

Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi
por: Khundi, McEwen, et al.
Publicado: (2022)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis
por: Svensson, RJ, et al.
Publicado: (2016)

Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria
por: Ulasi, Amara, et al.
Publicado: (2022)

Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis
por: Uchoa, Breno Kristoffer Beleza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bo37vs1f1o0l18876fbekr01b5